电製药/生物电医学市场规模、份额和成长分析（按产品类型、设备类型、应用、最终用户和地区）：产业预测（2025-2032）

2023年，全球电子药物/生物电药物市场规模将达到239亿美元，从2024年的253.6亿美元成长到2032年的407.2亿美元。预计将达6.1 %。

由于慢性和急性疾病盛行率上升、人口老化以及主要企业的进步等几个关键因素，生物电子医学市场预计将显着增长。一个值得注意的倡议是，2022年1月，生物电子医学促进会推出“生物电子医学日”，强调该领域的重要性。结合生物工程、分子医学和神经病学的电子製药设备在慢性疾病的治疗中变得越来越重要，特别是心血管疾病，这种疾病每年夺走美国超过 61 万人的生命。对新技术的研发和监管核准的大量投资继续增加市场潜力，但严格的政府法规和潜在的产品召回带来了挑战。这些因素的结合导致市场格局迅速发展和扩大。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术分析
• 监管分析
• 专利分析
• 案例研究

全球电製药/生物电医学市场规模/复合年增长率：依产品分类（2025-2032）

• 市场概况
• 心臟心律调节器/植入式心臟整流去颤器(ICD)
• 人工电子耳
• 脊髓刺激设备
• 深层脑部刺激器
• 迷走神经刺激设备
• 荐骨神经刺激器
• 其他的

全球电製药/生物电医学市场规模/复合年增长率：按设备类型划分（2025-2032）

• 市场概况
• 植入式装置
• 非侵入性设备

全球电製药/生物电医学市场规模/复合年增长率：按应用分类（2025-2032）

• 市场概况
• 心律不整
• 感觉神经性听力损失
• 癫痫
• 帕金森氏症
• 其他的

全球电製药/生物电医学市场规模/复合年增长率：按最终用户划分（2025-2032）

• 市场概况
• 医院
• 门诊手术中心
• 其他的

全球电製药/生物电医学市场规模/复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• 美敦力（爱尔兰）
• 雅培（美国）
• 波士顿科学公司（美国）
• 科利耳有限公司（澳洲）
• LivaNova PLC（英国）
• Biotronik SE & Co. KG（德国）
• electroCore, Inc.（美国）
• 索诺瓦（瑞士）
• Nevro 公司（美国）
• Stimwave LLC（美国）
• SetPoint 医疗（美国）
• 天空医疗科技（英国）
• 卡拉健康（美国）
• NeuroPace, Inc.（美国）
• Koninklijke Philips NV（荷兰）
• WEINMANN 紧急医疗技术有限公司（德国）
• 索诺瓦控股公司（瑞士）
• 奥迪康医疗 AB（丹麦）
• 生物电子公司（美国）
• MicroTransponder 公司（美国）

结论和建议

Global Electroceuticals Bioelectric Medicine Market size was valued at USD 23.9 billion in 2023 and is poised to grow from USD 25.36 billion in 2024 to USD 40.72 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The bioelectronic medicine market is poised for significant growth, driven by several key factors, including the rising incidence of chronic and acute diseases, an aging population, and advancements made by leading companies. A notable initiative was the launch of Bioelectronic Medicine Day by the Alliance for Advancing Bioelectronic Medicine in January 2022, highlighting the importance of this field. Electroceutical devices that blend bioengineering, molecular medicine, and neurology are increasingly relevant in treating chronic conditions, particularly cardiovascular diseases, which claim over 610,000 lives annually in the U.S. Significant investments in R&D and regulatory approvals for new technologies continue to enhance market potential, though strict government regulations and potential product recalls pose challenges. The convergence of these factors suggests a rapidly evolving and expanding market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals Bioelectric Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Bioelectric Medicine Market Segmental Analysis

Global Electroceuticals Bioelectric Medicine Market is segmented by Product, Device Type, Application, End User and region. Based on Product, the market is segmented into Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators and Others. Based on Device Type, the market is segmented into Implantable Devices and Non-invasive Devices. Based on Application, the market is segmented into Arrhythmia, Sensorineural Hearing Loss, Epilepsy, Parkinson's Disease and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Bioelectric Medicine Market

The global Electroceuticals Bioelectric Medicine market is primarily driven by the increasing prevalence of neurological and cardiovascular complications among the aging population, which requires innovative medical solutions. As this demographic grows, it fuels the demand for electroceutical devices such as cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators. Emerging economies, particularly in regions like South Korea, Malaysia, Vietnam, Africa, Israel, Saudi Arabia, and the UAE, present significant growth opportunities for major market players due to their favorable regulatory environments and improving healthcare infrastructures. The expanding patient base and rising healthcare costs further enhance the market's potential, prompting companies to focus on these emerging markets while facing intensified competition in more developed regions.

Restraints in the Global Electroceuticals Bioelectric Medicine Market

The growth of the Global Electroceuticals Bioelectric Medicine market is significantly hampered by the high costs associated with electroceutical devices, such as cochlear implants and neurostimulators, particularly in price-sensitive regions like Asia Pacific, Latin America, and Africa. Many healthcare providers in developing nations, such as Brazil and Mexico, lack the necessary financial resources to invest in advanced technologies. Furthermore, effective deployment of these devices requires extensive training for personnel, adding another layer of difficulty. The need for significant research and development to produce innovative electroceutical products increases manufacturing costs. Additionally, the shortage of skilled professionals, including neurologists and neurosurgeons, further restricts the availability of neurosurgical procedures, negatively impacting market demand for devices like neurostimulators.

Market Trends of the Global Electroceuticals Bioelectric Medicine Market

The Global Electroceuticals Bioelectric Medicine market is witnessing significant growth driven by the increasing acceptance of advanced medical devices such as defibrillators and pacemakers. Technological advancements, exemplified by Abbott Laboratories' FDA-approved Gallant line featuring Bluetooth-integrated implantable cardioverter-defibrillators, are expanding the market's capabilities. The introduction of modern pacemakers equipped with data recording, safe MRI compatibility, and remote monitoring functionalities further stimulates demand. As healthcare providers and patients increasingly recognize the benefits of these innovative therapies, the market is poised for robust expansion, enhancing patient outcomes and driving investments in this burgeoning field of bioelectric medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Electroceuticals Bioelectric Medicine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cardiac Pacemakers and Implantable Cardioverter Defibrillators
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Others

Global Electroceuticals Bioelectric Medicine Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Implantable Devices
• Non-invasive Devices

Global Electroceuticals Bioelectric Medicine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Arrhythmia
• Sensorineural Hearing Loss
• Epilepsy
• Parkinson's Disease
• Others

Global Electroceuticals Bioelectric Medicine Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Electroceuticals Bioelectric Medicine Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• electroCore, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SetPoint Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sky Medical Technology (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cala Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oticon Medical AB (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioElectronics Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations